An Global Comparative Observational Study of RoActemra/Actemra (Tocilizumab) in Patients With Rheumatoid Arthritis

Brussels

Kyiv

Brussels

Westmalle

Edegem

Genk

Liège

Basel

Catamarca Capital

Verviers

Heusy

Aarau

Mendoza

Mendoza

Godinne

Aye

Chur

Assebroek

Ostend

Ghent

Sankt Gallen

Aalst

Turin

Turin

Montevideo

Athens

Montevideo

Berlin

Ludwigsfelde

Arenzano

Rostock

Legnano

Milan

Milan

Mexicali

Hamburg

Hamburg

Brescia

Pátrai

Madrid

Madrid

San Sebastián de los Reyes

Madrid

Fuenlabrada

Kmelnytskyy

Panama City

Udine

Fulda

Wuppertal

Guadalajara

Guadalajara

Herne

Guadalajara

Cologne

Aachen

Bad Neuenahr-Ahrweiler

Thessaloniki

Prato

Jesi Ancona

Kharkiv

Odesa

Pescara

Coppito

Heidelberg

Zaporizhzhya

Stuttgart

Brindisi

San Cesario di Lecce

Martina Franca

Napoli

Napoli

München

München

Bad Aibling

Donetsk

Avellino

Traunstein

Salerno

Agnone

Uzhhorod

Reggio Calabria

Erlangen

Passau

Catania

Bayreuth

Erfurt

Rosario

Barranquilla

Bogotá

Bucaramanga

Medellín

Cuenca

Portoviejo

Guatemala City

Esmeraldas

Guayaquil

Quito

Quito

Quito

Dresden

Athens

Thessaloniki

Rome

Rome

Perugia

Mexico Ctiy

Almada

Amadora

Lisbon

Lisbon

Porto

Porto

Vila Nova de Gaia

Kyiv

Kyiv

Barnsley

Basildon

Basingstoke

Brighton

Cannock

Cardiff

Chertsey

Crawley

Darlington

Enfield

Grimsby

Guildford

Ipswich

Kettering

Lancaster

Leeds

Llandudno

London

London

London

Luton

Maidstone

Margate

Metropolitan Borough of Wirral

North Shields

Oswestry

Plymouth

Portsmouth

Reading

Rhyl

Romford

Sheffield

Stockport

Sunderland

Swindon

Torquay

Warrington

Wolverhampton

Wrightington